Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosis

Journal of Clinical Immunology

Volumn 33, Issue 7, 2013, Pages 1250-1256

  Picarelli, Antonio ^a   Di Tola, Marco ^a   Borghini, Raffaele ^a   Isonne, Claudia ^a   Saponara, Annarita ^a   Marino, Mariacatia ^a   Casale, Rossella ^a   Tiberti, Antonio ^a   Pica, Roberta ^b   Donato, Giuseppe ^a   Frieri, Giuseppe ^c   Corazziari, Enrico ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SANDRO PERTINI HOSPITAL   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Celiac disease; defensive medicine; esophagogastroduodenoscopy; organ culture system; pancolonoscopy

Indexed keywords

AUTOANTIBODY; ENDOMYSIUM ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ABDOMINAL PAIN; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL POLYP; CONTROLLED STUDY; DIARRHEA; ENTERITIS; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTROINTESTINAL SYMPTOM; GLUTEN FREE DIET; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; IRON DEFICIENCY ANEMIA; MALE; ORGAN CULTURE; ORGAN CULTURE TECHNIQUE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; SEROLOGY; SIGMOID; SUPERNATANT; WEIGHT REDUCTION;

ADULT; AUTOANTIBODIES; CELIAC DISEASE; CELLS, CULTURED; COLON, SIGMOID; COLONOSCOPY; CONNECTIVE TISSUE; FEMALE; GLUTENS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MUCOUS MEMBRANE; ORGAN CULTURE TECHNIQUES; SEROLOGIC TESTS; TRANSGLUTAMINASES; YOUNG ADULT;

EID: 84885190044     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-013-9920-3     Document Type: Article

References (31)

1. Picarelli A, Maiuri L, Frate A, Greco M, Auricchio S, Londei M. Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with celiac disease. Lancet. 1996;348:1065-7.
2. Picarelli A, Sabbatella L, Di Tola M, Di Cello T, Vetrano S, Anania MC. Antiendomysial antibody detection in fecal supernatants. In vivo proof that small bowel mucosa is the site of antiendomysial antibody production. Am J Gastroenterol. 2002;97:95-8.
3. Abadie V, Sollid LM, Barreiro LB, Jabri B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol. 2011;29:493-525.
4. Bao F, Green PH, Bhagat G. An update on celiac disease histopathology and the road ahead. Arch Pathol Lab Med. 2012;136:735-45.
5. Picarelli A, Di Tola M, Vallecoccia A, Libanori V, Magrelli M, Carlesimo M, et al. Oral mucosa patch test: a new tool to recognize and study the adverse effects of dietary nickel exposure. Biol Trace Elem Res. 2011;139:151-9.
6. Carroccio A, Campisi G, Iacono G, Lo Iacono O, Maresi E, Di Prima L, et al. Oral mucosa of celiac disease patients produces antiendomysial and antitransglutaminase antibodies: the diagnostic usefulness in vitro culture system. Aliment Pharmacol Ther. 2007;25:1471-7.
7. Vetrano S, Zampaletta U, Anania MC, Di Tola M, Sabbatella L, Passarelli F, et al. Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated celiac disease. Dig Liver Dis. 2007;39:911-6.
8. Noah TK, Donahue B, Shroyer NF. Intestinal development and differentiation. Exp Cell Res. 2011;317:2702-10.
9. Peytremann-Bridevaux I, Arditi C, Froehlich F, O'Malley J, Fairclough P, Le Moine O, et al. Appropriateness of colonoscopy in Europe (EPAGE II). Iron-deficiency anemia and hematochezia. Endoscopy. 2009;41:227-33.
10. Ransohoff DF, Pignone M. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2001;344:1022-3.
11. Gupta A, Samadder J, Elliott E, Sethi S, Schoenfeld P. Prevalence of adenomas and advanced adenomas in patients in the 40- to 49-year age group undergoing screening colonoscopy because of a family history of adenoma/polyp in a first-degree relative. Gastrointest Endosc. 2012;75:705-11.
12. Martínez-Ochoa E, Gómez-Acebo I, Beunza JJ, Rodríguez-Cundín P, Dierssen-Sotos T, Llorca J, et al. Influence of family history of colorectal cancer on health behavior and performance of early detection procedures: the SUN project. Ann Epidemiol. 2012;22:511-9.
13. Elli L, Tenca A, Soncini M, Spinzi G, Buscarini E, Conte D. Defensive medicine practices among gastroenterologists in Lombardy: Between lawsuits and the economic crisis. Dig Liver Dis. 2013 Feb 8 [Epub ahead of print].
14. Reilly NR, Green PH. Epidemiology and clinical presentations of celiac disease. Semin Immunopathol. 2012;34:473-8.
15. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185-94.
16. Davila RE, Rajan E, Baron TH, Adler DG, Egan JV, Faigel DO, et al. ASGE guideline colorectal cancer screening and surveillance. Gastrointest Endosc. 2006;63:546-57.
17. Picarelli A, Sabbatella L, Di Tola M, Vetrano S, Maffia C, Picchi C, et al. Forty-eight hours of biopsy culture improve the sensitivity of the in vitro gliadin challenge in the diagnosis of celiac disease. Clin Chem. 2001;47:1841-3.
18. Carroccio A, Di Prima L, Pirrone G, Scalici C, Florena AM, Gasparin M, et al. Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis. Clin Chem. 2006;52:1175-80.
19. Santaolalla R, Fernández-Bañares F, Rodríguez R, Alsina M, Rosinach M, Mariné M, et al. Diagnostic value of duodenal antitissue transglutaminase antibodies in gluten-sensitive enteropathy. Aliment Pharmacol Ther. 2008;27:820-9.
20. Picarelli A, Di Tola M, Marino M, Libanori V, Borghini R, Salvi E, et al. Usefulness of the organ culture system when villous height/crypt depth ratio, intraepithelial lymphocyte count, or serum antibody tests are not diagnostic for celiac disease. Transl Res. 2013;161:172-80.
21. Tosco A, Aitoro R, Auricchio R, Ponticelli D, Miele E, Paparo F, et al. Intestinal anti-tissue transglutaminase antibodies in potential celiac disease. Clin Exp Immunol. 2013;171:69-75.
22. Carroccio A, Iacono G, Di Prima L, Pirrone G, Cavataio F, Ambrosiano G, et al. Antiendomysium antibodies assay in the culture medium of intestinal mucosa: an accurate method for celiac disease diagnosis. Eur J Gastroenterol Hepatol. 2011;23:1018-23.
23. Lähteenoja H, Mäki M, Viander M, Toivanen A, Syrjänen S. Local challenge of oral mucosa with gliadin in patients with celiac disease. Clin Exp Immunol. 2000;120:38-45.
24. Lähteenoja H, Mäki M, Viander M, Räihä I, Vilja P, Rantala I, et al. Local challenge on oral mucosa with an alpha-gliadin related synthetic peptide in patients with celiac disease. Am J Gastroenterol. 2000;95:2880-7.
25. Bhatti TR, Jatla M, Verma R, Bierly P, Russo PA, Ruchelli ED. Lymphocytic gastritis in pediatric celiac disease. Pediatr Dev Pathol. 2011;14:280-3.
26. Casella G, Villanacci V, Di-Bella C, De-Marco E, Pagni F, Drera E, et al. Colonoscopic findings in celiac disease on a gluten-free diet. Rev Esp Enferm Dig. 2010;102:538-41.
27. Not T, Ziberna F, Vatta S, Quaglia S, Martelossi S, Villanacci V, et al. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. Gut. 2011;60:1487-93.
28. Picarelli A, Di Tola M, Sabbatella L, Mastracchio A, Trecca A, Gabrielli F, et al. Identification of a new celiac disease subgroup: antiendomysial and anti-transglutaminase antibodies of IgG class in the absence of selective IgA deficiency. J Intern Med. 2001;249:181-8.
29. Farrace MG, Picarelli A, Di Tola M, Sabbatella L, Marchione OP, Ippolito G, et al. Presence of anti-"tissue" transglutaminase antibodies in inflammatory intestinal diseases: an apoptosis-associated event? Cell Death Differ. 2001;8:767-70.
30. Di Tola M, Sabbatella L, Anania MC, Viscido A, Caprilli R, Pica R, et al. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med. 2004;42:1092-7.
31. Di Tola M, Sabbatella L, Picarelli A. Presence of antitissue transglutaminase antibodies as a sign of tissue lesion. Clin Chem. 2002;48:393-4.